Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

1699968

	registered interest
	date	12/04/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Pharmacy: Finance
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what assessment she has made of the potential impact of medication costs on community pharmacies.
	tabling member constituency	Gosport
	tabling member printed	Dame Caroline Dinenage
	uin	20988
	answer	answer is ministerial correction date of answer 19/04/2024 answer text <p>Through the medicine margin survey, the Department assesses whether the reimbursement arrangements pay pharmacy contractors as agreed as part of the community pharmacy contractual framework (CPCF). The medicine margin survey considers what pharmacies paid for medicines by looking at their invoices compared to the amount reimbursed by the National Health Service. Where the survey finds that they have been underpaid, we increase the pharmacy contractors’ payments, and where they have been overpaid, we decrease payments.</p><p>Furthermore, where pharmacies cannot purchase products at or below the Drug Tariff NHS reimbursement price, Community Pharmacy England can request that the Department reassesses the reimbursement price. If a new reimbursement price is issued, this is known as a concessionary price.</p> answering member constituency Pendle answering member printed Andrew Stephenson grouped question UIN 20979 question first answered 19/04/2024 09:54:36 answering member 4044 label Biography information for Andrew Stephenson
	tabling member	4008 label Biography information for Dame Caroline Dinenage

1700007

	registered interest
	date	12/04/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Pharmacy: Finance
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what assessment she has made of the adequacy of the medication reimbursement mechanism for community pharmacists.
	tabling member constituency	Easington
	tabling member printed	Grahame Morris
	uin	20979
	answer	answer is ministerial correction date of answer 19/04/2024 answer text <p>Through the medicine margin survey, the Department assesses whether the reimbursement arrangements pay pharmacy contractors as agreed as part of the community pharmacy contractual framework (CPCF). The medicine margin survey considers what pharmacies paid for medicines by looking at their invoices compared to the amount reimbursed by the National Health Service. Where the survey finds that they have been underpaid, we increase the pharmacy contractors’ payments, and where they have been overpaid, we decrease payments.</p><p>Furthermore, where pharmacies cannot purchase products at or below the Drug Tariff NHS reimbursement price, Community Pharmacy England can request that the Department reassesses the reimbursement price. If a new reimbursement price is issued, this is known as a concessionary price.</p> answering member constituency Pendle answering member printed Andrew Stephenson grouped question UIN 20988 question first answered 19/04/2024 09:54:35 answering member 4044 label Biography information for Andrew Stephenson
	tabling member	3973 label Biography information for Grahame Morris

1700110

	registered interest
	date	12/04/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Mental Health Services: Suffolk
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps her Department is taking to improve access to mental health services in Suffolk Coastal constituency.
	tabling member constituency	Suffolk Coastal
	tabling member printed	Dr Thérèse Coffey
	uin	21029
	answer	answer is ministerial correction date of answer 19/04/2024 answer text <p>The National Health Service forecasts that, between 2018/19 and 2023/24, spending on mental health services has increased by £4.7 billion in cash terms, compared to the target of £3.4 billion set out at the time of the NHS Long Term Plan. All integrated care boards are also on track to meet the Mental Health Investment Standard in 2023/24.</p><p>Almost £16 billion was invested in mental health in 2022/23, enabling over 3.5 million people, including in the Suffolk Coastal constituency, to be in contact with mental health services, a 10% increase on the previous year.</p> answering member constituency Lewes answering member printed Maria Caulfield question first answered 19/04/2024 10:02:57 answering member 4492 label Biography information for Maria Caulfield
	tabling member	4098 label Biography information for Dr Thérèse Coffey

1700151

	registered interest
	date	12/04/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Dental Services: Finance
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, if she will make an assessment of the potential impact of offering one-off payments to dentists that agree to work in under-served areas on the morale of other dentists.
	tabling member constituency	York Central
	tabling member printed	Rachael Maskell
	uin	21132
	answer	answer is ministerial correction date of answer 19/04/2024 answer text <p>We want to encourage all professionals to commit more of their time to National Health Service work, and to work in areas of the country with low provision of NHS dental care. That is why we are introducing Golden Hellos, as set out in our plan to reform and recover NHS dentistry. A golden hello of £20,000 will be offered per dentist, for a total of up to 240 dentists. The Golden Hellos will support practices in areas where recruitment is particularly challenging and make a real difference to those patients needing dental care.</p> answering member constituency South Northamptonshire answering member printed Andrea Leadsom question first answered 19/04/2024 09:51:49 answering member 4117 label Biography information for Andrea Leadsom
	tabling member	4471 label Biography information for Rachael Maskell

1700217

	registered interest
	date	12/04/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Maternity Services: Labour Turnover
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps her department is taking to improve retention rates of NHS maternity staff.
	tabling member constituency	Lewisham West and Penge
	tabling member printed	Ellie Reeves
	uin	21199
	answer	answer is ministerial correction date of answer 19/04/2024 answer text <p>The NHS Long Term Workforce Plan sets out how to improve culture and leadership, to ensure that up to 130,000 fewer staff leave the National Health Service over the next 15 years. This includes: implementing actions from the NHS People Plan that have been shown to be successful; implementing plans to improve flexible opportunities for prospective retirees, and delivering the actions needed to modernise the NHS pension scheme; and committing to ongoing national funding for continuing professional development for nurses, midwives, and allied health professionals, so NHS staff are supported to meet their full potential. These measures apply across staff groups, including maternity staff.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 19/04/2024 08:42:26 answering member 4044 label Biography information for Andrew Stephenson
	tabling member	4620 label Biography information for Ellie Reeves

1700242

	registered interest
	date	12/04/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Atorvastatin: Shortages
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what discussions she has had with stakeholders on tackling shortages of atorvastatin.
	tabling member constituency	Ellesmere Port and Neston
	tabling member printed	Justin Madders
	uin	21098
	answer	answer is ministerial correction date of answer 19/04/2024 answer text <p>There have been supply issues with atorvastatin, but as a result of our work to manage those issues, including engaging with alternative suppliers to cover supply gaps in order to meet demand, they have now been resolved.</p><p> </p><p>The medicine supply chain is highly regulated, complex, and global. Supply disruption is an issue which affects the United Kingdom, as well as other countries around the world. There can be a variety of causes, including manufacturing issues, problems with access to raw ingredients, and sudden spikes in demand.</p><p> </p><p>Whilst we can’t always prevent supply issues, the Department has well-established tools and processes to manage them, in order to mitigate risks to patients. We work closely with the pharmaceutical industry, NHS England, the Medicines and Healthcare products Regulatory Agency, and others operating in the supply chain to help ensure patients continue to have access to suitable medicines when supply is disrupted.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 19/04/2024 10:15:51 answering member 4044 label Biography information for Andrew Stephenson
	tabling member	4418 label Biography information for Justin Madders

1700243

	registered interest
	date	12/04/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Ezetimibe: Shortages
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what discussions she has had with relevant stakeholders on tackling shortages of Ezetimibe.
	tabling member constituency	Ellesmere Port and Neston
	tabling member printed	Justin Madders
	uin	21099
	answer	answer is ministerial correction date of answer 19/04/2024 answer text <p>The Department is aware of supply issues affecting several Ezetimibe suppliers. We are engaging with these suppliers to address the issues, and are working with alternative suppliers to ensure supplies remain available.</p><p>The medicine supply chain is highly regulated, complex, and global. Supply disruption is an issue which affects the United Kingdom, as well as other countries around the world. There can be a variety of causes, including manufacturing issues, problems with access to raw ingredients, and sudden spikes in demand.</p><p> </p><p>Whilst we can’t always prevent supply issues, the Department has well-established tools and processes to manage them, in order to mitigate risks to patients. We work closely with the pharmaceutical industry, NHS England, the Medicines and Healthcare products Regulatory Agency, and others operating in the supply chain to help ensure patients continue to have access to suitable medicines when supply is disrupted.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 19/04/2024 10:21:51 answering member 4044 label Biography information for Andrew Stephenson
	tabling member	4418 label Biography information for Justin Madders

1700244

	registered interest
	date	12/04/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Etoricoxib: Shortages
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what discussions she has had with relevant stakeholders on tackling shortages of Etoricoxib.
	tabling member constituency	Ellesmere Port and Neston
	tabling member printed	Justin Madders
	uin	21100
	answer	answer is ministerial correction date of answer 19/04/2024 answer text <p>The Department is aware that a supplier of etoricoxib 60 milligram tablets is experiencing a supply issue. We have been working with that supplier to address the issue, and resupply is expected in early May 2024. We have worked with alternative suppliers to ensure they can cover the gap in the market in the meantime.</p><p>The medicine supply chain is highly regulated, complex, and global. Supply disruption is an issue which affects the United Kingdom, as well as other countries around the world. There can be a variety of causes, including manufacturing issues, problems with access to raw ingredients, and sudden spikes in demand.</p><p>Whilst we can’t always prevent supply issues, the Department has well-established tools and processes to manage them, in order to mitigate risks to patients. We work closely with the pharmaceutical industry, NHS England, the Medicines and Healthcare products Regulatory Agency, and others operating in the supply chain to help ensure patients continue to have access to suitable medicines when supply is disrupted.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 19/04/2024 10:11:19 answering member 4044 label Biography information for Andrew Stephenson
	tabling member	4418 label Biography information for Justin Madders

1700385

	registered interest
	date	12/04/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Attention Deficit Hyperactivity Disorder: Diagnosis
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps her Department is taking to help reduce (a) assessment and (b) diagnosis waiting times for ADHD.
	tabling member constituency	Lewisham West and Penge
	tabling member printed	Ellie Reeves
	uin	21272
	answer	answer is ministerial correction date of answer 19/04/2024 answer text <p>It is the responsibility of integrated care boards to make appropriate provision available, to meet the health and care needs of their local population, including access to attention deficit hyperactivity disorder (ADHD) assessments, in line with relevant National Institute for Health and Care Excellence (NICE) guidelines. The NICE’s guidelines for ADHD diagnosis and management aim to improve the diagnosis of ADHD, as well as the quality of care and support people receive. The NICE’s guidelines do not recommend a maximum waiting time standard for ADHD diagnosis, either from referral for an assessment to receiving an assessment, a diagnosis, or a first contact appointment.</p><p>There is, at present, no single, established dataset that can be used to monitor waiting times for the assessment or treatment for ADHD nationally. The Department is exploring options to improve data collection and reporting on ADHD assessment waiting times, to help improve access to ADHD assessments in a timely way and in line with the NICE’s guideline. In support of this, the National Institute for Health and Care Research’s Policy Research Programme has commissioned a research project to provide insights into local ADHD diagnosis waiting time data collection.</p><p>NHS England is establishing a new ADHD taskforce alongside the Government, to improve care for people living with the condition. The new taskforce will bring together expertise from across a broad range of sectors, including the National Health Service, education, and justice, to better understand the challenges affecting people with ADHD, and help provide a joined up approach in response to concerns around rising demand for assessments and support.</p><p>Alongside the work of the taskforce, NHS England has announced that it will continue to work with stakeholders to develop a national ADHD data improvement plan, carry out more detailed work to understand the provider and commissioning landscape, and capture examples from local health systems who are trialling innovative ways of delivering ADHD services, to ensure best practice is captured and shared across the system.</p> answering member constituency Lewes answering member printed Maria Caulfield question first answered 19/04/2024 10:09:54 answering member 4492 label Biography information for Maria Caulfield
	tabling member	4620 label Biography information for Ellie Reeves

1700437

	registered interest
	date	12/04/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Mental Health Services: Children
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps she is taking to ensure that seriously ill children and their families can access information on how to access emotional and psychological support.
	tabling member constituency	Streatham
	tabling member printed	Bell Ribeiro-Addy
	uin	21324
	answer	answer is ministerial correction date of answer 19/04/2024 answer text <p>The clinical team responsible for a seriously ill child’s physical healthcare should discuss and review their emotional and psychological status regularly with them, or their family, and support them with access to information and services for their mental health if needed. Commissioners are encouraged to ensure local pathways include assessment and ongoing support of patients’ mental and psychological wellbeing and cognitive status.</p><p>The Health and Care Act 2022 placed a legal duty on integrated care boards (ICBs) to commission palliative and end of life care services, which meet the needs of their whole population. To support ICBs in this, NHS England has published statutory guidance, along with service specifications for children and young people, which make reference to including a holistic approach to care. This includes links to social prescribing, assessing, and addressing the needs of children, young people and families, and clear referral pathways to other services such as children and young people’s mental health services. The statutory guidance and the service specifications for children and young people are available respectively at the following links:</p><p><a href="https://eur03.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.england.nhs.uk%2Fpublication%2Fpalliative-and-end-of-life-care-statutory-guidance-for-integrated-care-boards-icbs%2F&amp;data=05%7C02%7CShirley.Tobin%40dhsc.gov.uk%7C0cf52c00176d4207242208dc5e4f4e74%7C61278c3091a84c318c1fef4de8973a1c%7C1%7C0%7C638488941907386165%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C0%7C%7C%7C&amp;sdata=Y2NBku%2BN73Psi5%2BuBNW0dCaPOjecLKzotN6jJcs3n%2BU%3D&amp;reserved=0" target="_blank">https://www.england.nhs.uk/publication/palliative-and-end-of-life-care-statutory-guidance-for-integrated-care-boards-icbs/</a></p><p><a href="https://www.england.nhs.uk/publication/service-specifications-for-palliative-and-end-of-life-care-children-and-young-people-cyp/" target="_blank">https://www.england.nhs.uk/publication/service-specifications-for-palliative-and-end-of-life-care-children-and-young-people-cyp/</a></p><p>Patients’ family members who feel they need emotional and psychological support should speak to their general practice, or can self-refer to NHS Talking Therapies online. Details are available on the NHS website.</p> answering member constituency Lewes answering member printed Maria Caulfield question first answered 19/04/2024 10:05:11 answering member 4492 label Biography information for Maria Caulfield
	tabling member	4764 label Biography information for Bell Ribeiro-Addy